Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
Matthew Guo, Joseph C. Murray, Paola Ghanem, Khinh Ranh Voong, Russell K. Hales, David S. Ettinger, Vincent K. Lam, Christine L. Hann, Patrick M. Forde, Julie R. Brahmer, Benjamin Levy, Josephine Feliciano, Kristen A. Marrone
Topics & Concepts
KRASMedicineDurvalumabOncologyInternal medicineLung cancerProgression-free survivalCancerImmunotherapyChemotherapyColorectal cancerPembrolizumabLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers